FDA Label for Australian Gold Metro 365 Medicated Leave-in Treatment Step 3
View Indications, Usage & Precautions
Australian Gold Metro 365 Medicated Leave-in Treatment Step 3 Product Label
The following document was submitted to the FDA by the labeler of this product Prime Enterprises Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredients
Pyrithione Zinc 0.22%
Purpose
Antidandruff
Indications
- Controls the symptoms of dandruff.
- Helps prevent recurrence of scalp itching and flaking associated with dandruff.
Warnings
For external use only.
When Using This Product
- Avoid contact with the eyes. If contact occurs, rinse eyes thouroughly with water.
Stop Use And Ask A Doctor
- If condition worsens or does not improve after regular use of this product as directed.
Keep Out Of Reach Of Children.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Shake well
- Use after shampooing and towel drying hair. Part hair section by section. Apply directly onto the scalp and spread using fingertips. Gently massage into scalp. Leave in.
- Apply to affected areas one to four times daily or as directed by a doctor.
- Children under 6 months of age: ask a doctor.
Inactive Ingredient
Caprylyl Glycol, Ceteareth-20, Cetearyl Alcohol, Cetrimonium Bromide, Cetyl Alcohol, Chlorphenesin, Disodium EDTA, Elaeis Guineensis (Palm) Oil, Fragrance, Glycerin, Phenoxyethanol, Propylene Glycol, Stearyl Dihydroxypropyldimonium Oligosaccharides, Water, may contain Citric Acid, may contain Sodium Hydroxide
Other Information
- Protect from heat.
Questions Or Comments?
Call toll free 1-855-548-4653
Australian Gold Metro 365 Medicated Leave-In Treatment Step 3
* Please review the disclaimer below.
